Resources

Peptide Therapeutics

2 whitepapers from Mumbai Biocluster and summit sessions. Sign in to view or download the full PDFs.

All 3D Cell Culture & NAMs Analytical Methods Biologics & Regulation Biomanufacturing & CDMO Peptide Therapeutics STEM & Policy

The 2026 Semaglutide Patent Expiry: Transformation of the Indian Metabolic Healthcare Landscape

Analyses the expiry of core semaglutide patent protection in India on March 20, 2026 and the wave of generic launches that followed, including approvals, pricing and accessibility strategies.

20 Mar 2026 · PDF · 6.3 MB

Peptide Therapeutics

Structural, Chemical, and Clinical Frontiers in the Development of Oral Semaglutide: A Strategic Perspective on Peptidomimetic Engineering

How GLP-1 receptor agonists moved from injectables to oral formulations, covering semaglutide's structural modifications, such as Aib substitution and fatty-diacid acylation, and the engineering challenges of oral delivery.

1 Feb 2026 · PDF · 2.5 MB